Watchmaker Genomics to Debut CRISPR-Based Library Normalization and High-Fidelity Amplification Technologies at ESHG 2026
核心洞察
Watchmaker Genomics (搜索) will unveil the EquiPlex Normalization Kit and Equinox Prime Library Amplification Master Mix at the ESHG 2026 conference in Gothenburg, Sweden on June 15.
EquiPlex repurposes CRISPR-Cas9 (搜索) as a stoichiometric molecular binding tool to enable rapid, automated library normalization without concentration QC or dilution steps.
Equinox Prime is engineered to reduce polymerase slippage in homopolymer and repetitive genomic regions, improving indel accuracy for oncology workflows including MSI profiling.
Watchmaker Genomics (搜索), a Boulder, Colorado-based leader in high-performance next-generation sequencing (NGS) workflow solutions, announced it will unveil two new technologies at the European Society of Human Genetics (ESHG) 2026 conference in Gothenburg, Sweden. The launches—the EquiPlex Normalization Kit and Equinox Prime Library Amplification Master Mix—are designed to address persistent bottlenecks in sequencing workflow scalability and amplification accuracy that continue to challenge high-throughput genomics labs and oncology-focused sequencing applications.
"Sequencing workflows continue to grow in scale and complexity, but many of the core bottlenecks researchers face today remain fundamentally unchanged," said Trey Foskett, CEO of Watchmaker. "These launches reflect our focus on engineering technologies that not only improve data quality but also simplify workflows and enable researchers to operate more efficiently at scale."
EquiPlex: CRISPR-Cas9 (搜索) Repurposed for Library Normalization
The EquiPlex Normalization Kit introduces a novel approach to library normalization by repurposing CRISPR-Cas9 (搜索) technology as a stoichiometric molecular binding tool rather than a cutting enzyme. The technology captures a fixed number of molecules from each library, regardless of the starting concentration, enabling rapid, automated normalization across a broad range of applications and sample types.
The workflow eliminates the need for library concentration quality control (QC), dilution calculations, and variable-volume pipetting steps—procedures that are difficult to automate, error-prone, and commonly contribute to pooling variability and sequencing imbalance. EquiPlex is compatible with existing RNA-seq, DNA-seq, and methylation sequencing workflows, designed to streamline sequencing operations and improve pooling consistency without requiring researchers to redesign established library preparation processes.
"Normalization of libraries prior to pooling has always been an annoyance, especially when working at scale," noted Graham Wiley, PhD, Director of Clinical Genomics Center at Oklahoma Medical Research Foundation. "Our previous pipelines would often still have an amount of variability that left us needing to perform additional sequencing to reach coverage goals. With Equiplex we've finally found the level of pooling consistency we were searching for."
Watchmaker is further adapting this CRISPR-enabled normalization strategy as a core component of a novel PCR-free whole genome sequencing solution, designed to streamline fragmentation, normalization, and library construction for labs requiring robust, reproducible, high-quality WGS data at scale.
Equinox Prime: Addressing Indel Accuracy in Challenging Genomic Regions
The Equinox Prime Library Amplification Master Mix is a next-generation amplification solution engineered to reduce polymerase slippage in homopolymer and repetitive genomic regions prone to indel artifacts. The technology was designed to improve variant calling accuracy in applications where indel precision is critical, including somatic oncology workflows such as microsatellite instability (MSI) profiling.
Beyond improved indel accuracy, Equinox Prime delivers low error rates, high library yields, and uniform GC coverage to support demanding sequencing workflows where amplification performance directly impacts downstream sequencing quality. The solution also provides broad performance benefits across whole genome sequencing (WGS), whole exome sequencing (WES), and other sequencing applications.
"Researchers have historically had to make trade-offs in library amplification performance, balancing yield and coverage uniformity against sequencing accuracy depending on the application," said Brian Kudlow, CSO of Watchmaker. "Equinox Prime was engineered to eliminate those compromises by delivering improved indel accuracy in repetitive regions alongside low error rates, high yields, and even GC coverage in a single solution."
ESHG 2026 Debut
Watchmaker will showcase these advances in its featured workshop titled "From Multiomics to Multiplexing: Integrated Advances in DNA, RNA, and Epigenomic Profiling" on Monday, June 15. The workshop will highlight new approaches for improving sequencing quality, simplifying workflows, and enabling scalable genomics across DNA, RNA, and epigenomic applications.
Built on Watchmaker's expertise in protein engineering and integrated workflow design, both technologies reflect the company's continued focus on solving real-world sequencing challenges that impact operational efficiency, scalability, and downstream data quality. The company is dedicated to advancing breakthrough technologies to support innovations in cancer detection, epigenetics, and liquid biopsy applications.